The pathogenesis of lyme neuroborreliosis: From infection to inflammation

Molecular Medicine

Volumn 14, Issue 3-4, 2008, Pages 205-212

  Rupprecht, Tobias A ^a   Koedel, Uwe ^a   Fingerle, Volker ^a   Pfister, Hans Walter ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; OUTER SURFACE PROTEIN A VACCINE; OUTER SURFACE PROTEIN C VACCINE; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BLOOD BRAIN BARRIER; BORRELIA BURGDORFERI; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DISEASE COURSE; HOST; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTE; LYME DISEASE; NERVE CELL; NERVE CELL LESION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SPIROCHETE; THROMBOCYTE; TICK BITE;

ANIMALS; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LIPOPROTEINS; LYME NEUROBORRELIOSIS; NEURONS;

EID: 41649118420     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00091.Rupprecht     Document Type: Review

References (107)

1. Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA (1999) Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur. J. Clin. Microbiol. Infect. Dis. 18:697-703.
2. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T (2003) Lyme borreliosis. Lancet Infect. Dis. 3:489-500.
3. Wilske B, Fingerle V, Schulte-Spechtel U (2007) Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol. 49:13-21.
4. Pfister HW, Wilske B, Weber K (1994) Lyme borreliosis: basic science and clinical aspects. Lancet 343:1013-6.
5. Pfister HW, Rupprecht TA (2006) Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients. Int. J. Med. Microbiol. 9:11-6.
6. Garin C, Bujadoux C (1922) Paralysie par les tiques. J. Med. Lyon 71:765-7.
7. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP (1982) Lyme disease: a tick-borne spirochetosis? Science 216:1317-9.
8. Pfister HW, Einhaupl K, Preac-Mursic V, Wilske B, Schierz G (1984) The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome). J. Neurol. 231:141-4.
9. Pachner AR, Gelderblom H, Cadavid D (2001) The rhesus model of Lyme neuroborreliosis. Immunol. Rev. 183:186-204.
10. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U (2005) The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 65:448-50.
11. Pachner AR, Amemiya K, Delaney E, O'Neill T, Hughes CA, Zhang WF (1997) Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology 49:147-52.
12. Cepok S, et al. (2003) The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. Arch. Neurol. 60:849-55.
13. Comstock LE, Fikrig E, Shoberg RJ, Flavell RA, Thomas DD (1993) A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Infect. Immun. 61:423-31.
14. Thomas DD, Comstock LE (1989) Interaction of Lyme disease spirochetes with cultured eucaryotic cells. Infect. Immun. 57:1324-1326.
15. Garcia-Monco JC, Villar BF, Szczepanski A, Benach JL (1991) Cytotoxicity of Borrelia burgdorferi for cultured rat glial cells. J. Infect. Dis. 163:1362-6.
16. Rupprecht TA, et al. (2006) Adhesion of Borrelia garinii to neuronal cells is mediated by the interaction of OspA with proteoglycans. J. Neuroimmunol. 175:5-11.
17. Rupprecht TA, et al. (2007) Borrelia garinii induces CXCL13 production in human monocytes through TLR2. Infect. Immun. 75:4351-6.
18. Pal U, et al. (2004) TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 119:457-68.
19. de Silva AM, Telford SR III, Brunet LR, Barthold SW, Fikrig E (1996) Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183:271-5.
20. Fikrig E, Telford SR III, Barthold SW, Kantor FS, Spielman A, Flavell RA (1992) Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc. Natl. Acad. Sci. U. S. A. 89:5418-21.
21. Walport MJ (2001) Complement. First of two parts. N. Engl. J. Med. 344:1058-66.
22. Schroder NW, et al. (2004) Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol. 173:2683-91.
23. Hirschfeld M, et al. (1999) Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382-6.
24. Sellati TJ, et al. (1999) Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins. J. Immunol. 163:2049-56.
25. Montgomery RR, Lusitani D, de Boisfleury CA, Malawista SE (2002) Human phagocytic cells in the early innate immune response to Borrelia burgdorferi. J. Infect. Dis. 185:1773-9.
26. Montgomery RR, Nathanson MH, Malawista SE (1993) The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages: destruction, survival, recovery. J. Immunol. 150:909-15.
27. Moore MW, et al. (2007) Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production. Infect. Immun. 75:2046-62.
28. Sadziene A, Barbour A (1996) Experimental immunization against Lyme Borreliosis with recombinant Osp proteins: an overview. Infection 24:195-202.
29. Lovrich SD, Jobe DA, Schell RF, Callister SM (2005) Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human Lyme disease and do not occur in mice or hamsters. Clin. Diagn. Lab. Immunol. 12:746-51.
30. Steere AC, Glickstein L (2004) Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4:143-52.
31. Norris SJ (2006) Antigenic variation with a twist: the Borrelia story. Mol. Microbiol. 60:1319-22.
32. Morrison TB, Weis JH, Weis JJ (1997) Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J. Immunol. 158:4838-45.
33. Häupl T, et al. (1997) Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines. FEMS Immunol. Med. Microbiol. 19:15-23.
34. Pal U, et al. (2000) Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Invest. 106:561-9.
35. Wilske B, Pfister HW (1995) Lyme borreliosis research. Curr. Opin. Infect. Dis. 8:137-144.
36. Schwan TG, Piesman J (2000) Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J. Clin. Microbiol. 38:382-8.
37. Ohnishi J, Piesman J, de Silva AM (2001) Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc. Natl. Acad. Sci. U. S. A. 98:670-5.
38. Cassatt DR, Patel NK, Ulbrandt ND, Hanson MS (1998) DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect. Immun. 66:5379-87.
39. Pal U, et al. (2004) OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J. Clin. Invest. 113:220-30.
40. Fingerle V, Goettner G, Gern L, Wilske B, Schulte-Spechtel U (2007) Complementation of a Borrelia afzelii OspC mutant highlights the crucial role of OspC for dissemination of Borrelia afzelii in Ixodes ricinus. Int. J. Med. Microbiol. 297:97-107.
41. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA (1995) Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. U. S. A. 92:2909-13.
42. Ramamoorthi N, et al. (2005) The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436:573-7.
43. Gilbert MA, Morton EA, Bundle SF, Samuels DS (2007) Artificial regulation of ospC expression in Borrelia burgdorferi. Mol. Microbiol. 63:1259-73.
44. Tilly K, Bestor A, Jewett MW, Rosa P (2007) Rapid clearance of Lyme disease spirochetes lacking OspC from skin. Infect. Immun. 75:1517-9.
45. Xu Q, Seemanapalli SV, McShan K, Liang FT (2006) Constitutive expression of outer surface protein C diminishes the ability of Borrelia burgdorferi to evade specific humoral immunity. Infect. Immun. 74:5177-84.
46. Pachner AR, et al. (2002) Humoral immune response associated with Lyme borreliosis in non-human primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins. Clin. Diagn. Lab. Immunol. 9:1348-55.
47. Cadavid D, O'Neill T, Schaefer H, Pachner AR (2000) Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab. Invest. 80:1043-54.
48. Tyson K, Elkins C, Patterson H, Fikrig E, de Silva A (2007) Biochemical and functional characterization of Salp20, an Ixodes scapularis tick salivary protein that inhibits the complement pathway. Insect Mol. Biol. 16:469-79.
49. Valenzuela JG, Charlab R, Mather TN, Ribeiro JM (2000) Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis. J. Biol. Chem. 275:18717-23.
50. Daix V, et al. (2007) Ixodes ticks belonging to the Ixodes ricinus complex encode a family of anti-complement proteins. Insect Mol. Biol. 16:155-66.
51. Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V (2002) Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody. Int. J. Med. Microbiol. 291 Suppl 33:141-6.
52. Alitalo A, et al. (2002) Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. J. Immunol. 169:3847-53.
53. Pausa M, et al. (2003) Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. J. Immunol. 170:3214-22.
54. Giambartolomei GH, Dennis VA, Philipp MT (1998) Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect. Immun. 66:2691-7.
55. Lazarus JJ, Meadows MJ, Lintner RE, Wooten RM (2006) IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J. Immunol. 177:7076-85.
56. Embers ME, Ramamoorthy R, Philipp MT (2004) Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease. Microbes Infect. 6:312-8.
57. Schutzer SE, Coyle PK, Reid P, Holland B (1999) Borrelia burgdorferi-specific immune complexes in acute Lyme disease. JAMA 282:1942-6.
58. Coyle PK, Schutzer SE, Belman AL, Krupp LB, Golightly MG (1990) Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes. Ann. Neurol. 28:739-44.
59. Liang FT, Brown EL, Wang T, Iozzo RV, Fikrig E (2004) Protective niche for Borrelia burgdorferi to evade humoral immunity. Am. J. Pathol. 165:977-85.
60. Cabello FC, Godfrey HP, Newman SA (2007) Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol. 15:350-4.
61. Fuchs H, Wallich R, Simon MM, Kramer MD (1994) The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor. Proc. Natl. Acad. Sci. U. S. A. 91:12594-8.
62. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL (1997) Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89:1111-9.
63. Coleman JL, Roemer EJ, Benach JL (1999) Plasmin-coated Borrelia burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix. Infect. Immun. 67:3929-36.
64. Sadziene A, Thomas DD, Bundoc VG, Holt SC, Barbour AG (1991) A flagella-less mutant of Borrelia burgdorferi: structural, molecular, and in vitro functional characterization. J. Clin. Invest. 88:82-92.
65. Zhao Z, Chang H, Trevino RP, Whren K, Bhawan J, Klempner MS (2003) Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute Lyme disease. J. Infect. Dis. 188:1098-104.
66. Fischer JR, LeBlanc KT, Leong JM (2006) Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect. Immun. 74:435-41.
67. Coburn J, Magoun L, Bodary SC, Leong JM (1998) Integrins α vβ 3 and α 5β 1 mediate attachment of Lyme disease spirochetes to human cells. Infect. Immun. 66:1946-52.
68. Guo BP, Norris SJ, Rosenberg LC, Hook M (1995) Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect. Immun. 63:3467-72.
69. Coburn J, Fischer JR, Leong JM (2005) Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol. Microbiol. 57:1182-1195.
70. Coulter P, et al. (2005) Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease. J. Clin. Microbiol. 43:5080-4.
71. Wormser GP, McKenna D, Carlin J, et al. (2005) Brief communication: hematogenous dissemination in early Lyme disease. Ann. Intern. Med. 142:751-5.
72. Coburn J, Leong JM, Erban JK (1993) Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc. Natl. Acad. Sci. U. S. A. 90:7059-63.
73. Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S (1997) Borrelia burgdorferi activates nuclear factor-κ B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J. Immunol. 158:3285-92.
74. Grab DJ, et al. (2005) Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect. Immun. 73:1014-22.
75. Szczepanski A, Furie MB, Benach JL, Lane BP, Fleit HB (1990) Interaction between Borrelia burgdorferi and endothelium in vitro. J. Clin. Invest. 85:1637-47.
76. Comstock LE, Thomas DD (1989) Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect. Immun. 57:1626-8.
77. Horstrup P, Ackermann R (1973) [Tick born meningopolyneuritis (Garin-Bujadoux, Bannwarth) (author's transl)]. Fortschr. Neurol. Psychiatr. Grenzgeb. 41:583-606.
78. Tatro J, Romero L, Beasley D, Steere A, Reichlin S (1994) Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J. Infect. Dis. 169:1014-22.
79. Grusell M, Widhe M, Ekerfelt C (2002) Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. J. Neuroimmunol. 131:173-8.
80. Widhe M, et al. (2004) Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J. Infect. Dis. 189:1881-91.
81. Weller M, Stevens A, Sommer N, Wiethölter H, Dichgans J. (1991) Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. Arch. Neurol. 48:837-41.
82. Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392:565-8.
83. Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A (1998) Chemokines and chemotaxis of leukocytes in infectious meningitis. J. Neuroimmunol. 85:33-43.
84. Brandes M, Legler DF, Spoerri B, Schaerli P, Moser B (2000) Activation-dependent modulation of B lymphocyte migration to chemokines. Int. Immunol. 12:1285-92.
85. Cepok S, et al. (2005) Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128(Pt 7):1667-76.
86. Narayan K, et al. (2005) The nervous system as ectopic germinal center: CXCL13 and IgG in Lyme neuroborreliosis. Ann. Neurol. 57:813-23.
87. Pashenkov M, et al. (2002) Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J. Neuroimmunol. 122:106-16.
88. Weis JJ, Ma Y, Erdile LF (1994) Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 62:4632-6.
89. Rupprecht TA, Koedel U, Angele B, Fingerle V, Pfister HW (2006) [Cytokine CXCL13: a possible early CSF marker for neuroborreliosis.]. Nervenarzt. 77:470-3.
90. Schutzer SE, et al. (1997) Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. J. Clin. Invest. 100:763-7.
91. Crowley H, Huber BT (2003) Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect. Immun. 71:4003-10.
92. + T cells in the central nervous system during the early phase of neuroborreliosis. J. Infect. Dis. 187:963-73.
93. Rupprecht TA, Koedel U, Muhlberger B, Wilske B, Fontana A, Pfister HW (2005) CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis. J. Neurol. 252:820-3.
94. + T-cells migrating into the cerebrospinal fluid of patients with neuroborreliosis: the role of CXCL10 and CXCL11. J. Neuroimmunol. 163:128-34.
95. Pachner AR, Steiner I (2007) Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 6:544-52.
96. Garcia-Monco J, Fernandez-Villar B, Benach J (1989) Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J. Infect. Dis. 160:497-506.
97. Peters DJ, Benach JL (1997) Borrelia burgdorferi adherence and injury to undifferentiated and differentiated neural cells in vitro. J. Infect. Dis. 176:470-7.
98. Garcia-Monco JC, Fernandez-Villar B, Rogers RC, Szczepanski A, Wheeler CM, Benach JL (1992) Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology 42:1341-8.
99. Ramesh G, et al. (2003) Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur. J. Immunol. 33:2539-50.
100. Norgard M, Arndt L, Akins D, Curetty L, Harrich D, Radolf J (1996) Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kB. Infect. Immun. 64:3845-52.
101. Roberts ED, et al. (1998) Pathogenesis of Lyme neuroborreliosis in the Rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J. Infect. Dis. 178:722-32.
102. Halperin JJ, Heyes MP (1992) Neuroactive kynurenines in Lyme borreliosis. Neurology 42:43-50.
103. Habicht GS, Katona LI, Benach JL (1991) Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J. Infect. Dis. 164:568-74.
104. Alaedini A, Latov N (2005) Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue. J. Neuroimmunol. 159:192-5.
105. Sigal LG, Tatum AH (1988) Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology 38:1439-42.
106. Sigal LH (1993) Cross-reactivity between Borrelia burgdorferi Flagellin and a human axonal 64.000 molecular weight protein. J. Infect. Dis. 167:1372-8.
107. Lengl-Janßen B, Strauss A, Steere AC, Kamradt T (1994) The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J. Exp. Med. 180:2069-78.